Phar1

Eli Lilly Secures $1.12 Billion Deal with Seamless Therapeutics to Target Hearing Loss through Gene‑Editing Technology

by

Here’s a breakdown of the key information from the provided text: * Lilly adn Seamless Therapeutics Deal: Eli Lilly (LLY.N) has signed a deal perhaps worth up to $1.12 billion … Read More

UK Prime Minister Starmer Sets Foot in China for First Visit Since 2018, Aiming to Strengthen Economic Ties Amid Rising Tensions

by

“`html British Prime Minister to Visit China with Key Economic Delegation Table of Contents 1. British Prime Minister to Visit China with Key Economic Delegation 2. Strengthening Economic Ties 3. … Read More

Graduate job cull spells doom for college degrees

by

AI Redefines the College Equation as Entry‑Level Jobs Shift Table of Contents 1. AI Redefines the College Equation as Entry‑Level Jobs Shift 2. AI’s Footprint Across Sectors 3. Headlines From … Read More

Samsung Biologics to buy US drug production facility from GSK for $280 million

by

Breaking News Table of Contents 1. Breaking News 2. Samsung Biologics to Acquire U.S. Drug-Production Facility via 100% Stake in Human Genome Sciences 3. Key Facts at a Glance 4. … Read More

FDA Approves AstraZeneca‑Daiichi Sankyo’s Enhertu with Roche

by

Reuters Reaffirms Trust Principles and Clarifies How to License Its Content Table of Contents 1. Reuters Reaffirms Trust Principles and Clarifies How to License Its Content 2. What the Thomson … Read More

Evaluating Optimal Timing for Hepatitis B Vaccination: Insights from Kennedy’s Vaccine Advisers

by

Kennedy Administration Weighs Major Shift in Hepatitis B Vaccination Policy Table of Contents 1. Kennedy Administration Weighs Major Shift in Hepatitis B Vaccination Policy 2. What evidence supports the claim … Read More

US, UK drug tariffs reduced to zero on condition of increased NHS spending and new drug price hikes | Reuters

by

US and UK Forge New Pharma Trade Pact: Tariffs Vanish, But UK Patients May Pay More WASHINGTON/LONDON – In a move poised to reshape the transatlantic pharmaceutical landscape, the United … Read More

European Doctors Advocate Novo Nordisk and Eli Lilly Weight-Loss Drugs as Primary Obesity Treatment Options

by

Most effective drugs for obesity and its complications are semaglutide, tirzepatide, new European guideline says Certain GLP-1 drugs are best for specific complications The non-binding guideline emphasizes economic considerations in … Read More

Eli Lilly raises obesity medication by 170% in the UK | Reuters

by

Eli Lilly’s Shocking Price Hike for Obesity Drug Manjaro in the UK: A Breaking News Update London, UK – August 14, 2024 – In a move sparking immediate concern, pharmaceutical … Read More

Angle: The reality of the Trump administration’s “investment attracting” and cases from the Biden era | Reuters

by

Breaking News: Trump’s $14 Trillion Investment Claim Under Scrutiny US President Donald Trump has boasted about attracting $14 trillion in new investments to the United States, but a recent Reuters … Read More